| Value | ₹14,264 Cr |
|---|
BSE filing, NSE: DCMSHRIRAM. Summary written from the filing by ALFA Finder's alert engine.
DCM Shriram Ltd: key numbers
- Share price
- ₹911.05
- Market cap
- ₹14,207 Cr
- Revenue (annual)
- ₹13,538 Cr
- Net profit (annual)
- ₹853.4 Cr
- P/E (TTM)
- 10.3×Sector 21.5×
- Promoter holding
- 66.52%+0.00% QoQ
- FII holding
- 3.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from DCM Shriram Ltd
All →DCM Shriram Production Started
DCM Shriram announced full commissioning of its ~68 MW wind-solar hybrid renewable power project. The project is held through SPV JSW Renew Energy Thirty Two Limited.
- wind-solar hybrid renewable power capacity
- 68.0 MW
DCM Shriram Earnings Call Transcript: Key Takeaways
Revenue grew 22% YoY, but EBITDA fell 22% due to soaring energy costs and lower agri margins.
DCM Shriram Investor Presentation: Key Takeaways
Q2 FY27 consolidated net revenue ₹3,977cr (+22%), PBDIT ₹319cr (-22%), PAT ₹106cr (-33%). Chemicals volume-led growth offset by margin squeeze.
DCM Shriram Results Update
DCM Shriram's press release reports Q2 FY27 consolidated revenue up 22% to ₹3,977 crore, with PBDIT and PAT lower. It also announces a 200% interim dividend.
DCM Shriram Dividend
DCM Shriram Ltd declared an interim dividend of Rs 2 per equity share for FY 2026-27 at its 26 October 2026 board meeting. Record date is 30 October 2026, with payment proposed by 25 November 2026.
DCM Shriram Acquisition Worth ₹50 Cr
DCM Shriram will invest up to Rs.50 Crore in cash, in tranches, in Shriram Teknor Limited. The investment supports PVC capacity expansion and speciality-grade diversification.
- Value
- ₹50.00 Cr
- Execution
- Indicative completion by 01-12-2027, in one or more tranches
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.